Halo Dream, Inc. recently secured a major technological breakthrough with the issuance of U.S. Patent No. 12721381. This patent, titled ‘Infant sleep garment with compression zone’, introduces a new approach to infant care and safety. Invented by Jessica Macari, Bridget McGrath, Winny Zhang, and Rachel Lindsey, this garment incorporates a targeted compression zone that mimics the soothing feeling of a gentle hug. This design helps reduce the startle reflex and promotes longer sleep periods without the need for loose blankets.

Innovative Design for Infant Sleep

The innovation focuses on integrating a specialized compression zone directly into a wearable sleep garment. Unlike traditional swaddles that can come undone or restrict movement, this garment provides gentle, localized pressure while allowing healthy hip development. By carefully engineering the elasticity and placement of the compression band, the design ensures the infant remains secure and comfortable. This precise construction provides peace of mind for parents by safely addressing common sleep disruptions.

Recognition from Swanson Reed

Because of its exceptional contribution to infant safety and product engineering, this invention won the patent of the month for the New York state for the month of October 2026 granted by Swanson Reed. The award highlights the garment’s ability to blend functional comfort with rigorous safety standards. Swanson Reed recognized the sophisticated textile engineering required to create a safe, breathable, and effective compression zone that supports better sleep patterns for babies.

R&D Tax Credit Eligibility

The practical applications of this patent demonstrate significant potential for Research and Development (R&D) tax credit eligibility in the USA. Developing the infant sleep garment required extensive testing of various fabrics, elasticity levels, and ergonomic designs to achieve the exact compression needed without compromising infant safety or breathability. The iterative process of prototyping, testing thermal regulation, and ensuring compliance with pediatric sleep guidelines constitutes qualified research activities. Companies investing in such technical uncertainties and advancing product development through systematic experimentation can leverage these efforts to claim substantial R&D tax credits, which helps offset the costs of bringing innovative and safe products to market.